Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes
Keywords: مقاومت داروی HIV-1; HIV-1 drug resistance; Non-subtype B; Integrase;
مقالات ISI مقاومت داروی HIV-1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure
Keywords: مقاومت داروی HIV-1; DRMs; drug resistance mutations; NGS; next generation sequencing; PGM; Ion Personal Genome Machine; MiSeq; Illumina MiSeq Sequencer; PMTCT; prevention of HIV mother to child transmission; cART; combination antiretroviral therapy; LPV/r; lopinavir/ritonavi
Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
Keywords: مقاومت داروی HIV-1; HIV-1 drug resistance; Allele-specific PCR; Ultra-deep sequencing; Low-frequency NNRTI variants;
HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure
Keywords: مقاومت داروی HIV-1; HIV-1 drug resistance; Antiretrovirals; Treatment response; Evolution; Bioinformatics;
Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE
Keywords: مقاومت داروی HIV-1; HIV-1 drug resistance; Thailand; HIV-1 CRF01_AE; Oligonucleotide ligation assay
A combined sequence-structure approach for predicting resistance to the non-nucleoside HIV-1 reverse transcriptase inhibitor Nevirapine
Keywords: مقاومت داروی HIV-1; Delaunay tessellation; Knowledge-based statistical potential; Computational mutagenesis; Machine learning; HIV-1 drug resistance; Prediction;
Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques
Keywords: مقاومت داروی HIV-1; HIV-1 drug resistance; Mucosal transmissibility; Pre-exposure prophylaxis
Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy
Keywords: مقاومت داروی HIV-1; HIV-1 drug resistance; HIV-1 recombination; HIV-1 tropism
HIV-1 drug resistance genotyping quality assessment: Results of the ENVA7 Genotyping Proficiency Programme
Keywords: مقاومت داروی HIV-1; ENVA7; HIV-1 drug resistance; External quality assessment
HIV-1 drug resistance patterns among treatment-naïve and therapy-experienced patients in Poland
Keywords: مقاومت داروی HIV-1; HIV-1 drug resistance; therapy naive; therapy experienced
Virological response to HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors-based, tenofovir DF-including regimens in the ANRS Aquitaine Cohort
Keywords: مقاومت داروی HIV-1; Nucleoside reverse transcriptase inhibitors; Tenofovir; Virological response; HIV-1 drug resistance
The HIV-1 reverse transcriptase mutants G190S and G190A, which confer resistance to non-nucleoside reverse transcriptase inhibitors, demonstrate reductions in RNase H activity and DNA synthesis from tRNALys, 3 that correlate with reductions in replication
Keywords: مقاومت داروی HIV-1; HIV-1 drug resistance; Replication fitness; RNase H cleavage; tRNALys, 3 priming; Efavirenz; G190S
Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART
Keywords: مقاومت داروی HIV-1; HIV-1; human immunodeficiency virus type 1; HAART; highly active antiretroviral therapy; PBMC; peripheral blood mononuclear cells; BDL; below detectable level; Pr; protease; RT; reverse transcriptase; PI; protease inhibitor; NRTI; nucleoside reverse trans